Apollo Endosurgery, Inc.: 10-Q filed 2013-11-08
What Apollo Endosurgery, Inc. reported in its quarterly report filed 2013-11-08 (fiscal Q3 2013): 27 published measures, 72 facts as tagged in accession 0001104659-13-082821.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-11-08
- Fiscal period
- fiscal Q3 2013
- Accession
- 0001104659-13-082821 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Apollo Endosurgery, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 17,967,066 | USD | |
| At 2012-12-31 | 27,183,533 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 7,614,086 | USD | |
| At 2012-12-31 | 12,238,813 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 10,352,980 | USD | |
| At 2012-12-31 | 14,944,720 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 14,914,675 | USD | |
| At 2012-12-31 | 24,621,083 | USD | |
| At 2012-09-30 | 16,020,441 | USD | |
| At 2011-12-31 | 14,410,630 | USD |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 37,734 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 154,751 | USD | 274 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 2,550,646 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 5,679,052 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 1,418,147 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 5,501,880 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -48,074,433 | USD | |
| At 2012-12-31 | -42,913,467 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 226,861 | USD | |
| At 2012-12-31 | 253,595 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 630,659 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 453,551 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -1,779,071 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -5,187,568 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -1,353,645 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -3,659,052 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 15,797,848 | USD | |
| At 2012-12-31 | 25,162,784 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 4,437,512 | USD | |
| At 2012-12-31 | 8,630,432 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 2,098,661 | USD | |
| At 2012-12-31 | 1,027,872 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 1,865,007 | USD | |
| At 2012-12-31 | 1,689,804 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 622,173 | USD | |
| At 2012-12-31 | 233,794 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 4,329,717 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 10,866,620 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 2,771,792 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 9,160,932 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 3,353,057 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 7,777,218 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 1,700,803 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 6,335,193 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 13,147,784 | shares | |
| At 2012-12-31 | 13,099,319 | shares |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 77,350 | USD | |
| At 2012-12-31 | 77,350 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 818,654 | USD | |
| At 2012-12-31 | 2,168,382 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 261,000 | USD | |
| At 2012-12-31 | 307,907 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -2,529,491 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -5,160,966 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -1,101,571 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -1,102,291 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 976,660 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 3,089,402 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 1,070,989 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 2,825,739 | USD | 274 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 161,461 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 74,994 | USD | 274 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -420 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 26,602 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -47,926 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -43,239 | USD | 274 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -750,420 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 26,602 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 252,074 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 2,556,761 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 388,379 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -962,050 | USD | 274 |
Inspect the source
- Entity
- Apollo Endosurgery, Inc. / CIK 0001251769
- Captured
- SEC response SHA-256
308ca5de51c5ff3a6ebe7ea06081848be77e7c3a8b2c9b2bce1d856f60a70fce
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001251769.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))